跳至主要内容
临床试验/JPRN-UMIN000034089
JPRN-UMIN000034089尚未招募未知

Development of prediction model for the efficacy of anti-PD-1 antibody on malignant pleural mesothelioma - Prediction model in MPM

Hyogo college of medicine0 个研究点目标入组 50 人开始时间: 2018年10月15日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1 Patients receiving pervious systemic chemotherapies (two or more regimens), including platinum agent and pemetrexede combination therapy. 2 Patients with ECOG PS 2 or more 3 Patients receiving steriod therapy (10mg per day or more) 4 Patients receiving antibiotics between 4 weeks before and after the nivolumab therapy 5 Patients who are deemed inappropriate as study participants by investigators or medical doctors.

研究者

相似试验